RBAIX
Price
$28.15
Change
+$0.08 (+0.29%)
Updated
Jul 3 closing price
Net Assets
4.82B
RLBFX
Price
$36.94
Change
+$0.18 (+0.49%)
Updated
Jul 3 closing price
Net Assets
252.39B
Interact to see
Advertisement

RBAIX vs RLBFX

Header iconRBAIX vs RLBFX Comparison
Open Charts RBAIX vs RLBFXBanner chart's image
T. Rowe Price Balanced I
Price$28.15
Change+$0.08 (+0.29%)
VolumeN/A
Net Assets4.82B
American Funds American Balanced R5
Price$36.94
Change+$0.18 (+0.49%)
VolumeN/A
Net Assets252.39B
RBAIX vs RLBFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RBAIX vs. RLBFX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RBAIX is a StrongBuy and RLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 252B vs. RBAIX (4.82B). RBAIX (2.15) and RLBFX (2.10) have matching dividends . RBAIX was incepted earlier than RLBFX: RBAIX (10 years) vs RLBFX (23 years). RBAIX (0.52) is less costly to investors than RLBFX (0.29). RLBFX is a more actively managed with annual turnover of: 44.00 vs. RBAIX (39.20). RLBFX has a lower initial minimum investment than RBAIX: RLBFX (250) vs RBAIX (500000). RLBFX annual gain was more profitable for investors over the last year : 8.18 vs. RBAIX (5.53). RLBFX return over 5 years is better than : 43.24 vs. RBAIX (25.93).
RBAIXRLBFXRBAIX / RLBFX
Total Expense Ratio0.470.29162%
Annual Report Gross Expense Ratio0.520.29179%
Fund Existence10 years23 years-
Gain YTD8.1368.22299%
Front LoadN/AN/A-
Min. Initial Investment500000250200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets4.82B252B2%
Annual Yield % from dividends2.152.10102%
Returns for 1 year5.538.1868%
Returns for 3 years29.6236.1382%
Returns for 5 years25.9343.2460%
Returns for 10 yearsN/A68.15-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMRK22.840.11
+0.48%
A-Mark Precious Metals
GALT2.180.01
+0.46%
Galectin Therapeutics
CRI32.19N/A
N/A
Carter's
MKC75.15-1.41
-1.84%
McCormick & Company
SONN3.92-0.23
-5.54%
Sonnet BioTherapeutics Holdings Inc